Fermented mushrooms

Highly bioactive beta-glucans

Cordyceps sinensis has been used as a medicine in China for over 300 years. Cordyceps sinensis has always been considered as the tonic for "all diseases" because it would improve energy, appetite, endurance, libido, endurance and sleep patterns. Cordyceps sinensis mycelium contains polysaccharides and cordycepin. In addition, it also contains other beneficial substances such as adenosine and amino acids that are required for the production of ATP. That is why this mushroom is mainly used for general fatigue and low energy levels. Numerous scientific studies show that Cordyceps sinensis polysaccharides (CSP) or cordycepin have various physiological and health effects, including rapid relief from fatigue, anti-inflammatory & antihypertensive properties, kidney protection and cell protection against PM2.5 or acute lung damage.

Submerged cultivation is the best technology to manage the identity and purity of medicinal mushrooms without contamination. The bioactive substances of mushrooms have been identified not only in the fruit body, but also in the mycelium culture and culture broth.

Cordyceps sinensis mycelium is a freeze-dried medicinal mushroom, produced by submerged cultivation and low temperature membrane filtration with molecular weight cut-off (MWCO) of 5,000 Da for high molecular weight and hence highly bioactive ß-glucans! This cultivated mycelium contains 100 % pure polysaccharides including ß-glucans derived from the mushroom. Many mushroom powders contain starch and other impurities derived from cereal-based cultivation. Therefore, these powders contain polysaccharides that do not come from the mushroom itself. The concentrations of these substances are thus often much higher.

Fermentation method
Deep-layer liquid state fermentation

Active compounds

Polysaccharides including β-glucans
Cordycepin
N6-2-hydroxyethyl adenosine(N6-HEA)

Recommended scientific dosage
Pure mycelium: 0.5 - 1.0 gram per day

Scientific evidence
Long-term storage assessment
Produced by patented submerged fermentation
Subjected to low temperature membrane filtration technology
Reliable strain identification by DNA Sequence alignment (ITS1, 5.8 DNA, ITS2)
Highly similarity with wild type (WT) strain
Analyses of active constituents and complete safety assessment
High content of secondary metabolites and bioactive components
Bio-sustainability, environment friendly, free of contaminants and heavy metals

Anti-fatigue
Anti-inflammatory properties
Boost physical strength
Immune system support
Improve respiratory function
Regulate blood pressure
Relieve common cold
Support chronic kidney disease

References

Kumar, R., Negi, P., Singh, B., Ilavazhagan, G., Bhargava, K., and Sethy, N.K. (2011). Cordyceps sinensis promotes exercise endurance capacity of rats by activating skeletal muscle metabolic regulators. Journal of ethnopharmacology 136, 260-266.
Lei, J., Wei, Y., Song, P., Li, Y., Zhang, T., Feng, Q., and Xu, G. (2018). Cordycepin inhibits LPS-induced acute lung injury by inhibiting inflammation and oxidative stress. European Journal of pharmacology 818, 110-114.
NB Research Center. (2018). The functional study of Cordyceps sinensis and its application for promoting health.
Xiang, F., Lin, L., Hu, M., and Qi, X. (2016). Therapeutic efficacy of a polysaccharide isolated from Cordyceps sinensis on hypertensive rats. International journal of biological macromolecules 82, 308-314.

EUROPE
Cordyceps sinensis is authorized in EU for use in food supplements.

BELGIUM
Cordyceps sinensis is permitted in Belgium. This mushroom is listed in The Royal Decree of 29 August 1997 on the manufacture and trade of foodstuffs composed or containing plants or plant preparations.

BELFRIT
Cordyceps sinensis is on the Belfrit list and is allowed in Belgium, France and Italy.

Fermedics offers you on request all technical data of this ingredient, such as Certificate of Analysis (COA), and price quotation.

Storage
Due to the hygroscopic nature, please store at dry conditions in an airtight container. Shelf life is at least two years at 25°C and below 70% RH in original sealed package.

MOQ (minimum order quantity) 25 kg

Ganoderma lucidum (Reishi), also known as ‘immortality mushroom’, is one of the best-known remedies in traditional Chinese medicine. According to legend, Ganoderma lucidum can cure all diseases, even help to achieve longevity, and its magical effect on saving someone's life. In regions of China and other Asian countries, G. lucidum has been used as a remedy to promote health and longevity. Ganoderma lucidum mycelium contains polysaccharides and ganoderic acid-A (GA-A) & ganoderic acid-B (GA-B). Numerous scientific studies show that G. lucidum polysaccharides (GLP) and GA-A & GA-B have various physiological and health effects, including strong antioxidant and immune modulating activities.Submerged cultivation is the best technology to manage the identity and purity of medicinal mushrooms without contamination. The bioactive substances of mushrooms have been identified not only in the fruit body, but also in the mycelium culture and culture broth. Ganoderma lucidum mycelium is a freeze-dried medicinal mushroom, produced by submerged cultivation and low temperature membrane filtration with molecular weight cut-off (MWCO) of 5,000 Da for high molecular weight and hence highly bioactive ß-glucans!
This cultivated mycelium contains 100 % pure polysaccharides including ß-glucans derived from the mushroom. Many mushroom powders contain starch and other impurities derived from cereal-based cultivation. Therefore, these powders contain polysaccharides that do not come from the mushroom itself. The concentrations of these substances are thus often much higher.

Fermentation method
Deep-layer liquid state fermentation

Active compounds

Ganoderic acid A (GA-A)
Ganoderic acid B (GA-B)
Polysaccharides (GLP) including β-glucans

Recommended scientific dosage
Pure mycelium: 0.5 - 1.0 gram per day

Scientific evidence
Long-term storage assessment
Produced by patented submerged fermentation
Subjected to low temperature membrane filtration technology
Reliable strain identification by DNA Sequence alignment (ITS1, 5.8 DNA, ITS2)
Highly similarity with wild type (WT) strain
Analyses of active constituents and complete safety assessment
High content of secondary metabolites and bioactive components
Bio-sustainability, environment friendly, free of contaminants and heavy metals

Anti-aging
Antioxidative and anti-inflammatory properties
Cardiovascular health support
Immunity support

References

Li, A., Shuai, X., Jia, Z., Li, H., Liang, X., Su, D., and Guo, W. (2015). Ganoderma lucidum polysaccharide extract inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation and function by inducing microRNA-125b. Journal of translational medicine 13, 100.
Li, K., Yu, M., Hu, Y., Ren, G., Zang, T., Xu, X., and Qu, J. (2016). Three kinds of Ganoderma lucidum polysaccharides attenuate DDC-induced chronic pancreatitis in mice. Chemico-biological interactions 247, 30-38.
Liang, Z., Yi, Y., Guo, Y., Wang, R., Hu, Q., and Xiong, X. (2014). Chemical characterization and antitumor activities of polysaccharide extracted from Ganoderma lucidum. International journal of molecular sciences 15, 9103-9116.
Radwan, F.F., Hossain, A., God, J.M., Leaphart, N., Elvington, M., Nagarkatti, M., Tomlinson, S., and Haque, A. (2015). Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid. Journal of cellular biochemistry 116, 102-114.
Sone, Y., Okuda, R., Wada, N., Kishida, E., and Misaki, A. (1985). Structures and anti-tumor activities of the polysaccharides isolated from fruiting body and the growing culture of mycelium of Ganoderma lucidum. Agricultural and Biological Chemistry 49, 2641-2653.
Zhang, G.-L., Wang, Y.-H., Ni, W., Teng, H.-L., and Lin, Z.-B. (2002). Hepatoprotective role of Ganoderma lucidum polysaccharide against BCG-induced immune liver injury in mice. World journal of gastroenterology 8, 728.

EUROPE
Ganoderma lucidum is authorized in EU for use in food supplements.

BELGIUM
Ganoderma lucidum is permitted in Belgium. This mushroom is listed in The Royal Decree of 29 August 1997 on the manufacture and trade of foodstuffs composed or containing plants or plant preparations.

BELFRIT
Ganoderma lucidum is on the Belfrit list and is allowed in Belgium, France and Italy.

Fermedics offers you on request all technical data of this ingredient, such as Certificate of Analysis (COA), and price quotation. Storage Due to the hygroscopic nature, please store at dry conditions in an airtight container. Shelf life is at least two years at 25°C and below 70% RH in original sealed package.

MOQ (minimum order quantity) 25 kg

Grifola frondosa (maitake) mushroom is an important ingredient in traditional Chinese and Japanese medicine, used for longevity and health. The maitake mushroom is known as an adaptogen. It treats both physical and mental ailments and balances the body. Maitake also has a beneficial effect on blood sugar levels and immune system. Scientific reports have shown that the mycelium of Grifola frondosa had anti-tumor, anti-inflammatory, antioxidant, anti-diabetic and anti-nephritic effects. Submerged cultivation is the best technology to manage the identity and purity of medicinal mushrooms without contamination. The bioactive substances of mushrooms have been identified not only in the fruit body, but also in the mycelium culture and culture broth. Grifola frondosa mycelium is a freeze-dried medicinal mushroom, produced by submerged cultivation and low temperature membrane filtration with molecular weight cut-off (MWCO) of 5,000 Da for high molecular weight and hence highly bioactive ß-glucans! This cultivated mycelium contains 100 % pure polysaccharides including ß-glucans derived from the mushroom. Many mushroom powders contain starch and other impurities derived from cereal-based cultivation. Therefore, these powders contain polysaccharides that do not come from the mushroom itself. The concentrations of these substances are thus often much higher.

Fermentation method
Deep-layer liquid state fermentation

Active compounds
Polysaccharides including β-glucans

Recommended scientific dosage
0.5 - 1.0 gram per day

Scientific evidence
Long-term storage assessment
Produced by patented submerged fermentation
Subjected to low temperature membrane filtration technology
Reliable strain identification by DNA Sequence alignment (ITS1, 5.8 DNA, ITS2)
Highly similarity with wild type (WT) strain
Analyses of active constituents and complete safety assessment
High content of secondary metabolites and bioactive components
Bio-sustainability, environment friendly, free of contaminants and heavy metals

Anti-inflammatory properties
Immunity support
Improving glycaemic levels
Increase stress resistance

References

Ji, H.-Y., Chen, P., Yu, J., Feng, Y.-y., and Liu, A.-j. (2018). Effects of heat treatment on the structural characteristics and antitumor activity of polysaccharides from Grifola frondosa. Applied Biochemistry and Biotechnology.
Kou, L., Du, M., Liu, P., Zhang, B., Zhang, Y., Yang, P., Shang, M., and Wang, X. (2019). Anti-diabetic and anti-nephritic activities of Grifola frondosa mycelium polysaccharides in diet-streptozotocin-induced diabetic rats via modulation on oxidative stress. Appl Biochem Biotechnol 187, 310-322.
Roca-Lema, D., Martinez-Iglesias, O., Fernandez de Ana Portela, C., Rodriguez A., Valladares-Ayerbes, M., Diaz-Diaz, A., Casas-Pais, A., Prego, C., and Figueroa, A. (2019). In Vitro anti-proliferative and anti-invasive effect of polysaccharide-rich extracts from Trametes Versicolor and Grifola Frondosa in colon cancer cells. International journal of medical sciences 16, 231-240.

EUROPE
Grifola frondosa is authorized in EU for use in food supplements.

BELGIUM
Grifola frondosa is permitted in Belgium. This mushroom is listed in The Royal Decree of 29 August 1997 on the manufacture and trade of foodstuffs composed or containing plants or plant preparations.

BELFRIT
Grifola frondosa is on the Belfrit list and is allowed in Belgium, France and Italy.

MOQ (minimum order quantity) 25 kg

Hericium erinaceus mushrooms, also known as 'Lion's Mane', have been used for centuries in Asia for their ability to support brain function.

Scientific studies have shown that hericium erinaceus mycelium helps improve recognition memory, cognitive behavior and memory. Submerged cultivation is the best technology to manage the identity and purity of medicinal mushrooms without contamination. The bioactive substances of mushrooms have been identified not only in the fruit body, but also in the mycelium culture and culture broth.

Hericium erinaceus mycelium is a freeze-dried medicinal mushroom, produced by submerged cultivation and low temperature membrane filtration with molecular weight cut-off (MWCO) of 5,000 Da for high molecular weight and hence highly bioactive ß-glucans! This cultivated mycelium contains 100 % pure polysaccharides including ß-glucans derived from the mushroom. Many mushroom powders contain starch and other impurities derived from cereal-based cultivation. Therefore, these powders contain polysaccharides that do not come from the mushroom itself. The concentrations of these substances are thus often much higher.

Fermentation method
Deep-layer liquid state fermentation

Active compounds

Erinacine A (only in fermented mycelium)
Polysaccharides including β-glucans

Recommended scientific dosage
0.5 - 1.0 gram per day

Scientific evidence
Long-term storage assessment
Produced by patented submerged fermentation
Subjected to low temperature membrane filtration technology
Reliable strain identification by DNA Sequence alignment (ITS1, 5.8 DNA, ITS2)
Highly similarity with wild type (WT) strain
Analyses of active constituents and complete safety assessment
High content of secondary metabolites and bioactive components
Bio-sustainability, environment friendly, free of contaminants and heavy metals

Antioxidative properties
Immunity support
Improving memory, focus & concentration

References

Brandalise, F., Cesaroni, V., Gregori, A., Repetti, M., Romano, C., Orru, G., Botta, L., Girometta, C., Guglielminetti, M.L., Savino, E., and Rossi, P. (2017). Dietary supplementation of Hericium erinaceus increases mossy fiber-CA3 hippocampal neurotransmission and recognition memory in wild-type mice. Evidence-based complementary and alternative medicine: eCAM 2017, 3864340.
Chen, T.-C., Huang, C.-C., and Chin, T.-Y. (2018). The effect of Hericium erinaceus mycelium and Erinaceus A in the rat model of hemiparkinsonism. NB reaseach center.
Tsai, Y.-C., Lin, Y.-C., Huang, C.-C., Villaflores, O.B., Wu, T.-Y., Huang, S.-M., and Chin, T.-Y. (2018). Hericium erinaceus mycelium and its isolated compound, Erinacine A, ameliorate high-fat high-sucrose diet-induced metabolic dysfunction and spatial learning deficits in aging mice. (in submission).
Wang, X.Y., Yin, J.Y., Zhao, M.M., Liu, S.Y., Nie, S.P., and Xie, M.Y. (2018). Gastroprotective activity of polysaccharide from Hericium erinaceus against ethanol-induced gastric mucosal lesion and pylorus ligation-induced gastric ulcer, and its antioxidant activities. Carbohydrate polymers 186, 100-109.

EUROPE
Hericium erinaceus is authorized in EU for use in food supplements.

BELGIUM
Hericium erinaceus is permitted in Belgium. This mushroom is listed in The Royal Decree of 29 August 1997 on the manufacture and trade of foodstuffs composed or containing plants or plant preparations.

BELFRIT
Hericium erinaceus is on the Belfrit list and is allowed in Belgium, France and Italy.

MOQ (minimum order quantity) 25 kg

Diabetes mellitus, better known as diabetes, is a metabolic disease that causes high blood sugar levels. Type I diabetes, also known as juvenile diabetes, occurs when the body fails to produce insulin. Type II diabetes affects the way the body uses insulin, in other words the cells in the body do not react as effectively as ever. Both in the prevention and treatment of diabetes, a healthy diet, regular exercise, normal body weight and controlling blood pressure are extremely important.

Scientific reports have shown that Inonotus obliquus mycelium has mainly anti-diabetic and anti-allergic effects. In addition, this mushroom is also used to support cancer and has a cytotoxic effect on cancer cells.

Inonotus obliquus mycelium is a freeze-dried medicinal mushroom, produced by submerged cultivation and low temperature membrane filtration with molecular weight cut-off (MWCO) of 5,000 Da for high molecular weight and hence highly bioactive ß-glucans! This cultivated mycelium contains 100 % pure polysaccharides including ß-glucans derived from the mushroom. Many mushroom powders contain starch and other impurities derived from cereal-based cultivation. Therefore, these powders contain polysaccharides that do not come from the mushroom itself. The concentrations of these substances are thus often much higher.

Fermentation method
Deep-layer liquid state fermentation

Active compounds

Betulinic acid
Inotodiol
Polysaccharides including β-glucans
Trametenolic acid

Recommended scientific dosage
0.5 - 1.0 gram per day

Scientific evidence
Long-term storage assessment
Produced by patented submerged fermentation
Subjected to low temperature membrane filtration technology
Reliable strain identification by DNA Sequence alignment (ITS1, 5.8 DNA, ITS2)
Highly similarity with wild type (WT) strain
Analyses of active constituents and complete safety assessment
High content of secondary metabolites and bioactive components
Bio-sustainability, environment friendly, free of contaminants and heavy metals

Antioxidative and anti-inflammatory properties
Cardiovascular support
Immunity support
Improving glycemic levels
Preventing abnormal pigmentation changes

References

Baek, J., Roh, H.-S., Baek, K.-H., Lee, S., Lee, S., Song, S.-S., and Kim, K.H. (2018). Bioactivity-based analysis and chemical characterization of cytotoxic constituents from Chaga mushroom (Inonotus obliquus) that induce apoptosis in human lung adenocarci noma cells. Journal of Ethnopharmacology 224, 63-75.
Cha, J.Y., Jun, B.S., Kim, J.W., Park, S.H., Lee, C.H., and Cho, Y.S. (2006). Hypoglycemic effects of fermented chaga mushroom (Inonotus obliquus) in the diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rat.
Glamočlija, J., Ćirić, A., Nikolić, M., Fernandes, A., Barros, L., Calhelha, R.C., Ferreira, I.C.F.R., Soković, M., and van Griensven, L.J.L.D. (2015). Chemical characterization and biological activity of Chaga (Inonotus obliquus), a medicinal “mushroom". Journal of Ethnopharmacology 162, 323-332.
Nguyet, T.M.N., Lomunova, M., Le, B.V., Lee, J.S., Park, S.K., Kang, J.S., Kim, Y.H., and Hwang, I. (2018). The mast cell stabilizing activity of Chaga mushroom critical for its therapeutic effect on food allergy is derived from inotodiol. International Immuno pharmacology 54, 286-295.
Wang, J., Wang, C., Li, S., Li, W., Yuan, G., Pan, Y., and Chen, H. (2017). Anti-diabetic effects of Inonotus obliquus polysaccharides in streptozotocin-induced type 2 diabetic mice and potential mechanism via PI3K-Akt signal pathway. Biomedicine & Pharmacotherapy 95, 1669-1677.
Zhang, X., Bao, C., and Zhang, J. (2018). Inotodiol suppresses proliferation of breast cancer in rat model of type 2 diabetes mellitus via downregulation of ß-catenin signal ing. Biomedicine & Pharmacotherapy 99, 142-150.

EUROPE
Inonotus obliquus is authorized in EU for use in food supplements.

BELGIUM
Inonotus obliquus is permitted in Belgium. This mushroom is listed in The Royal Decree of 29 August 1997 on the manufacture and trade of foodstuffs composed or containing plants or plant preparations.

BELFRIT
Inonotus obliquus is on the Belfrit list and is allowed in Belgium, France and Italy.

MOQ (minimum order quantity) 25 kg

The most common type of mushroom is Lentinula edodes, also called shiitake. Scientific studies show that the polysaccharides of the shiitake have many therapeutic uses, such as supporting immunity, improving hyperlipidemia and possessing antiviral and antibacterial properties. Submerged cultivation is the best technology to manage the identity and purity of medicinal mushrooms without contamination. The bioactive substances of mushrooms have been identified not only in the fruit body, but also in the mycelium culture and culture broth. Lentinula edodes mycelium is a freeze-dried medicinal mushroom, produced by submerged cultivation and low temperature membrane filtration with molecular weight cut-off (MWCO) of 5,000 Da for high molecular weight and hence highly bioactive ß-glucans! This cultivated mycelium contains 100 % pure polysaccharides including ß-glucans derived from the mushroom. Many mushroom powders contain starch and other impurities derived from cereal-based cultivation. Therefore, these powders contain polysaccharides that do not come from the mushroom itself. The concentrations of these substances are thus often much higher.

Fermentation method
Deep-layer liquid state fermentation

Active compounds
Polysaccharides including β-glucans

Recommended scientific dosage
0.5 - 1.0 gram per day

Scientific evidence
Long-term storage assessment
Produced by patented submerged fermentation
Subjected to low temperature membrane filtration technology
Reliable strain identification by DNA Sequence alignment (ITS1, 5.8 DNA, ITS2)
Highly similarity with wild type (WT) strain
Analyses of active constituents and complete safety assessment
High content of secondary metabolites and bioactive components
Bio-sustainability, environment friendly, free of contaminants and heavy metals
Quality control (QC) procedures with ISO22000, HACCP, ISO17025 and FDA registered

Anti-bacterial and anti-viral properties
Cardiovascular health support
Immune system support

References

Kuroki, T., Lee, S., Hirohama, M., Taku, T., Kumakura, M., Haruyama, T., Nagata, K., and Kawaguchi, A. (2018). Inhibition of influenza virus infection by Lentinus edodes mycelia extract through its direct action and immunopotentiating activity. Frontiers in microbiology 9, 1164.
Nagashima, Y., Yoshino, S., Yamamoto, S., Maeda, N., Azumi, T., Komoike, Y., Okuno, K., Iwasa, T., Tsurutani, J., Nakagawa, K., Masaaki, O., and Hiroaki, N. (2017). Lentinula edodes mycelia extract plus adjuvant chemotherapy for breast cancer patients: results of a randomized study on host quality of life and immune function improvement. Molecular and clinical oncology 7, 359-366.
Spim, S.R.V., de Oliveira, B.G.C.C., Leite, F.G., Gerenutti, M., and Grotto, D. (2017). Effects of Lentinula edodes consumption on biochemical, hematologic and oxidative stress parameters in rats receiving high-fat diet. European Journal of Nutrition 56, 2255-2264.

EUROPE
Lentinula edodes is authorized in EU for use in food supplements.

BELGIUM
Lentinula edodes is permitted in Belgium. This mushroom is listed in The Royal Decree of 29 August 1997 on the manufacture and trade of foodstuffs composed or containing plants or plant preparations.

BELFRIT
Lentinula edodes is on the Belfrit list and is allowed in Belgium, France and Italy.

MOQ (minimum order quantity) 25 kg

Paecilomyces hepiali, best known under the Cs-4 strain, is isolated from natural Chinese cordyceps. However, it must be considered as an independent cordyceps fungus, unlike associations with the Chinese cordyceps based on its phylogenetic origin.

Paecilomyces hepiali mycelium is a freeze-dried medicinal mushroom, produced by submerged cultivation and low temperature membrane filtration with molecular weight cut-off (MWCO) of 5,000 Da for high molecular weight and hence highly bioactive ß-glucans! This cultivated mycelium contains 100 % pure polysaccharides including ß-glucans derived from the mushroom. Many mushroom powders contain starch and other impurities derived from cereal-based cultivation. Therefore, these powders contain polysaccharides that do not come from the mushroom itself. The concentrations of these substances are thus often much higher.

Fermentation method
Deep-layer liquid state fermentation

Active compounds
Polysaccharides including β-glucans

Recommended scientific dosage
Pure mycelium: 0.5 - 1.0 gram per day

Scientific evidence
Long-term storage assessment
Produced by patented submerged fermentation
Subjected to low temperature membrane filtration technology
Reliable strain identification by DNA Sequence alignment (ITS1, 5.8 DNA, ITS2)
Highly similarity with wild type (WT) strain
Analyses of active constituents and complete safety assessment
High content of secondary metabolites and bioactive components
Bio-sustainability, environment friendly, free of contaminants and heavy metals

Regulation blood sugar level
Anti-fatigue effects
Antioxidant activity

EUROPE
Paecilomyces hepiali is authorized in EU for use in food supplements.

BELGIUM
Paecilomyces hepiali is permitted in Belgium. This mushroom is listed in The Royal Decree of 29 August 1997 on the manufacture and trade of foodstuffs composed or containing plants or plant preparations.

BELFRIT
Paecilomyces hepiali is on the Belfrit list and is allowed in Belgium, France and Italy.

Fermedics offers you on request all technical data of this ingredient, such as Certificate of Analysis (COA), and price quotation.

Storage
Due to the hygroscopic nature, please store at dry conditions in an airtight container. Shelf life is at least two years at 25°C and below 70% RH in original sealed package.

MOQ (minimum order quantity) 25 kg

Fermentation method
Deep-layer liquid state fermentation

Composition

Paecilomyces hepiali (CS4)
Ganoderma lucidum
Cordyceps sinensis
Lentinus edodes
Grifola frondosa

Active compounds

Cordycepin
Ganoderic acid A & B
N6-HEA
Polysaccharides including β-glucans

Recommended scientific dosage
0.5 - 1.0 gram per day

Anti-fatigue
Antioxidative and anti-inflammatory properties
Cardiovascular support
Immunity support
Increase stress resistance
Lung protection
Regulating blood sugar level
Stimulating physical strength

EUROPE
All mushrooms in FermycoTM are authorized in EU for use in food supplements.

BELGIUM
All mushrooms in FermycoTM are permitted in Belgium. All mushrooms are listed in The Royal Decree of 29 August 1997 on the manufacture and trade of foodstuffs composed or containing plants or plant preparations.

BELFRIT
All mushrooms in FermycoTM are on the Belfrit list and are allowed in Belgium, France and Italy.

MOQ (minimum order quantity) 25 kg

Want to know more about the scientific results of fermented mushrooms?

Yes please